Subscribe
gavel-istock-508411976_andreypopov
AndreyPopov / iStockphoto.com
15 February 2018Americas

USITC to investigate microfluidic systems complaint

The US International Trade Commission (ITC) will be launching a patent infringement investigation into microfluidic systems, following a complaint from 10x Genomics.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
10x Genomics sued over cell research tools
20 November 2018   Genome sequencing company 10x Genomics has been accused of infringing 11 patents covering cell research and analysis tools.
Americas
Bio-Rad wins injunction against 10X Genomics
26 July 2019   Bio-Rad, a developer of clinical diagnostic products, secured a permanent injunction against a competitor earlier this week in a long-running dispute.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Americas
Bio-Rad wins injunction against 10X Genomics
26 July 2019   Bio-Rad, a developer of clinical diagnostic products, secured a permanent injunction against a competitor earlier this week in a long-running dispute.
Americas
10x Genomics sued over cell research tools
20 November 2018   Genome sequencing company 10x Genomics has been accused of infringing 11 patents covering cell research and analysis tools.

More on this story

Americas
Bio-Rad wins injunction against 10X Genomics
26 July 2019   Bio-Rad, a developer of clinical diagnostic products, secured a permanent injunction against a competitor earlier this week in a long-running dispute.
Americas
10x Genomics sued over cell research tools
20 November 2018   Genome sequencing company 10x Genomics has been accused of infringing 11 patents covering cell research and analysis tools.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York